Brought to you by 
OncoMed Pharmaceuticals completes $88.8mm IPO
22 Aug 2013
Executive Summary
OncoMed Pharmaceuticals Inc. (cancer stem cell therapeutics) netted $88.8mm through its initial public offering. The company sold 5.6mm shares (including the overallotment) at $17, higher than the anticipated $14-16 range.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
OncoMed Pharmaceuticals completes $88.8mm IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice